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Plasmodium falciparum malaria is usually transmitted 
by mosquitoes. We report 2 cases in France transmitted by 
other modes: occupational blood exposure and blood trans-
fusion. Even where malaria is not endemic, it should be con-
sidered as a cause of unexplained acute fever.
U
nusual forms of parasitic infection, such as those ac-
quired by blood transfusion (1,2) or accidental expo-
sure to infected blood (3), may be challenging to diagnose 
in areas where these infections are not endemic (4). We re-
port 2 cases of Plasmodium falciparum malaria transmitted 
by routes other than mosquito vectors: occupational blood 
exposure and blood transfusion. 
The Patients
Patient 1, a 36-year-old woman who worked as a 
technician in a clinical laboratory, was admitted to Bor-
deaux Hospital, France, on June 2, 2009. She had a 7-day 
history of high fever (up to 39°5 C), rigors, headache, and 
jaundice. Hematologic tests showed decreased platelets 
(33,000 × 109 platelets/L) and increased serum C-reactive 
protein (130 mg/L; reference <5 mg/L). Although the pa-
tient denied having traveled abroad in the past 5 years, she 
lived near an international airport, and her clinical signs 
were typical of malaria. Consequently, thick and thin 
blood smears were performed and indicated P. falcipar-
um parasitemia of 0.1%. Serum bilirubin was 86 μmol/L 
(reference 3–18 μmol/L). By 6 hours after hospital ad-
mission, her condition had dramatically worsened, with 
hemodynamic collapse (blood pressure 60/32 mm Hg) as-
sociated with macroscopic hemoglobinuria; parasitemia 
increased to 6%. All viral and bacteriologic testing results 
were negative. Treatment was intravenous quinine for-
mate (loading dose 17 mg/kg, followed by maintenance 
dose of 8.3 mg/kg 3×/d). After 5 days, her medication was 
switched to oral quinine for another 2 days. Parasitemia 
was absent 6 days after starting quinine, and the patient 
was discharged 2 days later. Blood smears were negative 
21 days after discharge.
Patient 1 later recalled that 2 weeks before hospital ad-
mission she had been injured by a broken, blood-contami-
nated, malaria diagnostic (QBC) test tube at work. Because 
she considered the incident trivial, she did not inform her 
workplace of it. Had she done so, the standard blood ex-
posure protocol would have been automatically triggered. 
The source of the blood was subsequently traced to a pa-
tient returning from the Congo, for whom P. falciparum 
parasitemia of 4% had been diagnosed when the blood 
sample was taken. Genotyping of blood samples from pa-
tient 1 and the presumed source traveler were performed. P. 
falciparum isolates were genotyped at the 7A11, C4M79, 
Pf2802, and Pf2689 microsatellite loci and at the highly 
polymorphic loci of the merozoite surface protein 1 and 2 
antigen genes by ﬂ  uorescent end-labeled nested PCR and 
restriction fragment length polymorphism analysis (5–7). 
Results showed that the 2 infections had the same molecu-
lar signature and complete homology and were conﬁ  rmed 
by genotypic analysis of resistance markers. A threonine 
variant on codon K76T point mutation of P. falciparum 
chloroquine resistance transporter and an identical level of 
resistance to antifolate drugs (P. falciparum dihydrofolate 
reductase–thymidylate synthase point mutations at posi-
tions 51, 59, and 108) were found (Table) (5,7). A diagno-
sis of severe malaria as a result of occupational percutane-
ous blood exposure was therefore retained.
Patient 2 was a 15-day-old girl who was referred from 
Dakar, Senegal, where she had been born on March 11, 
2009. She was the third child of a Lebanese family who 
had no known genetic illness and who lived in an air-con-
ditioned house. The pregnancy had been uneventful, and 
the infant was delivered at term. Her blood group was B 
Rh+. At day 14 after birth, pallor and jaundice suggested 
severe neonatal anemia. Blood testing indicated decreased 
hemoglobinemia (5.2 g/dL; reference 9–14 g/dL) and retic-
ulocytosis (260,000 × 109 cells/L; reference 25,000–85,000 
× 109 cells/L). Serum C-reactive protein was <5 mg/L. The 
patient received a 60-mL whole blood transfusion from a 
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compatible donor in Dakar on March 26; the next day, she 
was transferred to Bordeaux Hospital.
At the time of admission, hematologic testing con-
ﬁ  rmed severe regenerative hemolytic anemia (hemoglobin 
9.5 g/dL, reticulocytes 320,000 × 109 cells/L, and serum 
haptoglobin <0.08 g/L [reference 0.80–2.15 g/L]). Abdom-
inal and transfontanellar echography showed no abnormal-
ities. PCR speciﬁ  c for parvovirus B19 and cytomegalovirus 
was negative. Serologic testing for malaria, thick and thin 
blood smear, and speciﬁ  c PCR for P. falciparum pBRK1–14 
in the newborn and her mother were negative. Investigation 
for ABO blood incompatibility or immunologically related 
hemolysis produced negative results. Screening of both 
parents and the newborn for inherited hemolysis excluded 
an erythrocyte membrane abnormality. Hemoglobinopathy 
and erythrocyte enzyme (glucose 6-phosphate dehydroge-
nase, pyruvate kinase, and hexokinase) deﬁ  ciencies were 
also ruled out. The newborn and her parents were followed 
up weekly; no pertinent clinical ﬁ  ndings or abnormal PCR 
and blood smear were found until 7 weeks after birth, when 
febrile thrombocytopenia (92,000 × 109 platelets/L) and 
neutropenia (540 × 109 cells/L) were detected.
At 7 weeks after birth, blood smears indicated P. fal-
ciparum parasitemia of 6%. Treatment with intravenous 
quinine formate at 8.3 mg/kg 3×/d for 4 days, followed by 
oral meﬂ  oquine (20 mg/kg) for 1 day led to prompt im-
provement. Follow-up at 3 and 5 months of age showed 
resolution of anemia and no relapse of malaria. Test results 
for hemolysis remained negative, and glucose 6-phosphate 
deshydrogenase and erythrocyte pyruvate kinase levels 6 
months after transfusion were within normal limits. Al-
though it could not be conﬁ  rmed, neonatal anemia was at-
tributed to fetal–maternal hemorrhage.
We contacted the clinic in Dakar, where the blood 
sample but not the donor could be traced. However, a thick 
and thin blood smear examination subsequently performed 
in Dakar was positive for P. falciparum, clearly supporting 
a diagnosis of transfusion-transmitted malaria.
Conclusions
In non–malaria-endemic countries, accidental blood-
borne inoculation of P. falciparum after direct occupational 
exposure of health care or laboratory personnel has been 
rarely reported (8–10). The course of such occupationally 
acquired malaria may be critical if the inoculating injury 
is neglected or unrecognized, as it was by patient 1. This 
case emphasizes the need for laboratories handling blood to 
ensure that every accidental injury, however trivial it may 
seem, is declared and managed. As occurred with patient 1, 
a delayed diagnosis may also delay delivery of appropriate 
care for preventing severe or complicated illness (9,10).
Whereas most non–malaria-endemic countries, includ-
ing France, are implementing selective screening strategies 
for blood product donors (11), prevention of transfusion-
transmitted malaria in endemic areas such as Senegal re-
mains a challenge because such screening is not routinely 
performed. For patients such as patient 2, malaria is rarely 
diagnosed in non–malaria-endemic countries (12,13). For 
this patient, the chronology of events and exposure to blood 
from a contaminated donor are highly suggestive of transfu-
sion-transmitted malaria. In the absence of immunologic in-
dicators that the mother had been exposed to P. falciparum, 
vertical transmission is extremely unlikely, and the risk for 
mosquito transmission is low because of the family’s liv-
ing environment and the time of year. Nevertheless, without 
gene sequencing of parasites from the donor, transfusion-
transmitted malaria cannot be demonstrated unequivocally.
Neonates are assumed to be able to counteract natural 
infection with malaria because of the predominance of fetal 
hemoglobin, which is not suitable for complete erythrocyte 
schizogony of P. falciparum (14). For patient 2, transfu-
sion with infected adult blood may have compromised this 
capacity, enabling the infection to follow its natural course. 
In Senegal, blood transfusion recipients are routinely given 
antimalaria treatment (15). Unfortunately, such treatment 
cannot be extended to neonates because of lack of a vali-
dated and convenient therapeutic antimalaria regimen for 
this age group.
The above-mentioned types of malaria transmission 
are unusual. However, in non–malaria-endemic countries, 
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Table. Genotyping results for 2 Plasmodium falciparum isolates, 
France, 2009* 
Locus
Secondary case Index case
Type Allele  Type  Allele 
Microsatellites†
 7A11 NA 119  bp NA 119  bp
 C4M79 NA 203 bp NA 203 bp
 Pf2802 NA 139 bp NA 139 bp
 Pf2689 NA 87 bp NA 87 bp
Antigen genes‡
msp-1 Ro33 149 bp Ro33 149 bp
msp-2 FC27 413 bp FC27 413 bp
Drug resistance genes§ 
 pfcrt codon 76 Mutated ACA Mutated ACA
pfdhfr
  Codon  16 Wild-type GCA Wild-type GCA
  Codon  51 Mutated ATT Mutated ATT
  Codon  59 Mutated CGT Mutated CGT
  Codon  108 Mutated AAC Mutated AAC
  Codon  164 Wild-type ATA Wild-type ATA
*NA, not applicable; msp, merozoite surface protein; pfcrt, P. falciparum
chloroquine resistance transporter; pfdhfr, P. falciparum dihydrofolate 
reductase. 
†Size of amplified DNA fragment expressed. 
‡Allelic family and size of amplified DNA fragment expressed. 
§Single-nucleotide polymorphism. pfcrt codon 76 point mutation was 
genotyped by nested PCR and restriction fragment-length polymorphism 
analysis. pfdhfr point mutations at positions 16, 51, 59, 108, and 164 were
genotyped by nested PCR and primer expansion. Underlining indicates 
nucleotide positions that can be mutated. a recent history of blood transfusion or an episode of acci-
dental inoculation of blood may account for malaria infec-
tion in persons who are not otherwise at risk.
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